- Home
- Applications
- europe
- vaccine development
Refine by
Vaccine Development Product Applications In Europe
4 applications found
Immune repertoire analysis has taken a predominant role in the development of vaccination strategies against infectious disease and has enabled characterization of the immune response against pathogens at high ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Current viral titer assay methods, a crucial component of vaccine & CGT development and production efforts, are generally slow, labor intensive, subjective, and difficult to standardize, often resulting in large errors or failures during critical production ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. The particles contain no viral genome and are replicative defective and non-pathogenic. The particle capsid surface has repetitive, immunogenic sites, where peptides of interest can be inserted and allows us to generate monovalent or bivalent vaccines as required. Each peptide of interest will be presented 60 times on the capsid surface and both the innate and adaptive immune systems are activated to ...
By2A Pharma ApS based in Aalborg Øst, DENMARK
Vaccine manufacturing has been widely popular ever since Pasteur developed the rabies vaccine in 1885. Since then vaccine manufacturing has continued to be popular due to the defense that vaccines provide against certain viruses. The human immune system is constantly defending itself against a barrage of viruses and we simply lack the capacity to recognize and fight against these ever changing pathogens. Vaccines ...
ByLonza Group Ltd based in Basel, SWITZERLAND